New Impact Factor (2023) and CiteScore

JIF = 3.1 (Q2 in WOS) and CiteScore 7.4 (top 10% in Scopus).

Read about our new impact factor, performace metrics, and reviewers in our Blog story.

Latest articles

BJBMS continuously publishes highly relevant and trending articles in the Advanced online section.
Check out the list of the most recently published articles here.

BJBMS becomes Biomolecules and Biomedicine

We are excited to annouce the title change of BJBMS from January 2023.
Find out more about this change in our Blog story, Editorial and the Frequently asked questions.

Reviews
S1P/S1PR signaling pathway advancements in autoimmune diseases

Ma et al.
Read more

Pharmacology
Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing reactive oxygen species, endoplasmic reticulum stress, and Pannexin-1-mediated ferroptosis

Sun et al.
Read more

New and emerging methods
Validation of Doi’s weighted average glucose as a measure of post-load glucose excursion for clinical use

Badran et al.
Read more

Reviews
Cannabinoids in cancer treatment: Therapeutic potential and legislation

Barbara Daris, Mojca Tancer Verboten, Zeljko Knez, Polonca Ferk
Read more

Photo Credits: Almir Hukic, Birds of Bosnia

Biomolecules and Biomedicine (formerly the Bosnian Journal of Basic Medical Sciences, BJBMS) is a comprehensive, multidisciplinary open-access medical journal dedicated to the advancement of medical research, practice, and education. The journal publishes pioneering research across the spectrum of pre-clinical studies, translational medicine, and clinical research, thereby advancing our collective knowledge in the realm of health and disease.
Find more information about the scope and aim here...

Edited by: Muzafer Mujic, MD, PhD and Semir Vranic, MD, PhD
 Journal Impact Factor® (2022): 3.4
5-year Journal Impact Factor®: 3.6
CiteScore® (2022): 5.3
 ISSN: 2831-0896 (Print)
ISSN: 2831-090X (Online)
Open Access
Frequency: Continuously published online. Six printed issues per year.
Published by: The Association of Basic Medical Sciences of FBIH

> Journal indexing and metrics
> Why publish with us?

NEWS, ANNOUNCEMENTS AND HIGHLIGHTS

Announcements

Celebrating Latest Achievements: CiteScore and Impact Factor 2023

03-07-2024

We are thrilled to announce that Biomolecules and Biomedicine Journal (formerly known as BJBMS) has reached remarkable milestones in 2023!

Metrics and Rankings

Our CiteScore has soared to 7.4, placing us in the 91st percentile—that’s the top 10% of all Scopus journals! Check out more on Scopus.

We’ve also achieved an Impact Factor of 3.1, placing us in the 54th percentile and Q2 in our category in the Web of Science. Dive deeper into our success on the Journal Citation Reports  or download the PDF report.

Read more about Celebrating Latest Achievements: CiteScore and Impact Factor 2023

Current Issue

Vol. 24 No. 3 (2024)
Published: 02-05-2024

Editorial

Reviews

Molecular Biology

Pharmacology

Anatomy

Translational and Clinical Research

New and Emerging Medical Entities

View All Issues